IVF Success Rate in Thailand: Real Influencing Factors and Clinical Data Analysis
Opening: Doctor's Decision Logic
Doctor's Decision Logic: Where Does the Success Rate Come From?
In reproductive medicine clinics, one of the most common questions patients ask is, "Doctor, what is my success rate with IVF?" The answer to this question depends on a comprehensive evaluation of a series of medical indicators. As a reproductive specialist, before giving a success rate prediction, a complete fertility assessment must be completed—including ovarian reserve function (AMH, FSH, antral follicle count), sperm quality (routine analysis plus DNA fragmentation rate), uterine environment (endometrial thickness, morphology, presence of adhesions or polyps), and overall health status (thyroid function, vitamin D levels, immune status, etc.). These indicators collectively determine a patient's individualized success rate.
The IVF success rate in Thailand is not an isolated number but the result of the interplay between the patient's own conditions and the level of medical technology. The same hospital and the same doctor may have success rates that differ several times for different patients. Therefore, my answer is usually not to give a percentage directly, but to first tell the patient: we need to complete certain tests first, and then make an individualized judgment based on the results.
The True Meaning of IVF Success Rate in Thailand
There is no unified official statistic for the IVF success rate in Thailand. Data reported by various reproductive centers differ in statistical methods, patient selection criteria, age distribution, and embryo culture protocols, making direct comparisons of limited value. Internationally recognized success rate evaluation standards include:
- Live birth rate per oocyte retrieval cycle (most stringent, reflecting the efficiency of the complete treatment cycle)
- Live birth rate per transfer cycle (most common, but does not account for patients who discontinue mid-treatment)
- Cumulative live birth rate (most comprehensive, covering results from multiple transfers)
Some reproductive centers in Thailand report success rates between 50% and 70%, but these data are usually based on specific age ranges and selected patient groups. For women under 35 with normal ovarian reserve and no other infertility factors, the live birth rate at well-known Thai hospitals is approximately 50%–60%, comparable to international advanced levels. However, it must be clear: success rate data are for reference only, not a guarantee.
Age is the Primary Variable Affecting Success Rate
Age is the most important factor influencing IVF success rates, and this applies equally in Thailand. The following data are based on international reproductive medicine statistics (referencing CDC, ESHRE, HFEA standards). Data reported by Thai hospitals may vary due to different statistical methods and patient selection.
| Age Group | Live Birth Rate per Transfer Cycle (Reference Range) | Clinical Explanation |
|---|---|---|
| Under 35 | 50%–60% | Ovarian reserve is usually good, embryo chromosomal normality rate is higher, cumulative live birth rate can reach 70%–80% |
| 35–37 years | 40%–50% | Ovarian reserve begins to decline; prompt initiation is recommended, benefits of PGT screening start to appear |
| 38–40 years | 25%–35% | Embryo chromosomal abnormality rate increases (approximately 40%–60%), PGT screening can significantly improve single transfer success rate |
| 41–42 years | 15%–25% | Live birth rate with own eggs drops significantly; sufficient embryo numbers are needed; cumulative live birth rate is more informative |
| Over 43 years | 5%–10% | Live birth rate with own eggs is extremely low; embryo chromosomal normality rate is less than 20%; egg donation is often considered |
The older the age, the greater the individual variation. Some women over 40 still have reasonable ovarian reserve; when AMH is above 1.5 ng/mL, it is still possible to obtain a certain number of embryos. Therefore, judgment cannot be based solely on age; it must be combined with indicators such as AMH, FSH, and antral follicle count for a comprehensive assessment.
Differences Between Hospitals and Embryology Labs
The differences in success rates among different reproductive centers in Thailand mainly stem from the following aspects:
- Embryo culture system: Blastocyst culture rate and freeze-thaw survival rate are core indicators. Air quality (VOC concentration), temperature control, and culture medium selection in the lab all affect embryo developmental potential.
- Embryologist experience: The experience of embryologists directly affects oocyte fertilization rate (especially ICSI procedures), accuracy of embryo grading, and success rate of PGT biopsy.
- Ovarian stimulation protocols: Different hospitals use different protocols (antagonist, short protocol, PPOS, luteal phase stimulation, etc.) with varying effects for different patient groups. Experienced doctors can adjust dynamically based on the patient's hormone levels.
- PGT technology: The accuracy and detectable range of chromosome screening technology vary between labs; NGS platforms have higher precision than aCGH.
When choosing a hospital, it is recommended to focus on the hospital's real data for your specific age group, rather than the overall success rate. Also, inquire about the hospital's embryo culture system (whether blastocyst culture is routine, whether time-lapse incubators are used, whether freezing technology is vitrification or slow freezing, etc.).
Four Most Easily Overlooked Influencing Factors
1. Sperm DNA Fragmentation Index (DFI)
When sperm DNA fragmentation index is above 30%, even if routine semen analysis is normal, it can lead to reduced fertilization rates, embryo developmental arrest, or miscarriage. In IVF treatment in Thailand, the male partner needs to complete semen analysis plus DFI testing. If DFI is above 30%, it is recommended to first undergo medication or surgical treatment (e.g., varicocele repair); in some cases, testicular sperm aspiration may be considered.
2. Endometrial Receptivity
Endometrial thickness, morphology, blood flow signals, and the presence of chronic endometritis all affect embryo implantation. For patients with repeated implantation failure, ERA testing (Endometrial Receptivity Analysis) or hysteroscopy is recommended. Chronic endometritis is not uncommon among IVF patients in Thailand, and antibiotic treatment can significantly improve pregnancy outcomes.
3. Vitamin D Levels
Vitamin D deficiency is associated with decreased IVF success rates. Thailand has abundant sunshine, but air-conditioned environments and sun protection habits can lead to vitamin D insufficiency. It is recommended to test 25-hydroxyvitamin D before starting the cycle, and if below 20 ng/mL, supplement to the normal range (>30 ng/mL).
4. Thyroid Function
TSH above 2.5 mIU/L is associated with an increased miscarriage rate. Thyroid function screening is required before IVF in Thailand; abnormalities should be adjusted to the normal range first. Subclinical hypothyroidism is occasionally seen in clinical practice, and pregnancy outcomes improve after levothyroxine supplementation.
Common Misconceptions and Pitfall Warnings
Myth 1: Only looking at the success rate number, ignoring the statistical method. Some hospitals report the "live birth rate per transfer cycle" rather than the "live birth rate per oocyte retrieval cycle." The latter better reflects the real situation because not all egg retrievals yield transferable embryos. It is recommended to pay attention to both the "live birth rate per oocyte retrieval cycle" and the "cumulative live birth rate."
Myth 2: Believing that being young guarantees success. Age is an important factor, but not the only one. Endometriosis, immune abnormalities (e.g., antiphospholipid syndrome), and coagulation disorders (e.g., thrombophilia) can all affect success rates in younger patients. When young patients experience repeated implantation failure, these factors need to be investigated.
Myth 3: Ignoring the male factor. In IVF treatment in Thailand, the male partner needs to complete semen analysis, DNA fragmentation testing, and genetic testing if necessary (e.g., Y chromosome microdeletion, karyotype analysis). Male factors are a significant cause of abnormal embryo development; approximately 30%–40% of embryo chromosomal abnormalities originate from sperm.
Myth 4: Over-trusting "success guaranteed" promises. Any marketing behavior that promises a success rate violates medical ethics. The success rate of IVF cannot be guaranteed in advance, and individual variation is enormous. Be highly vigilant towards agencies or institutions that claim "success guaranteed."
Key Examination Indicators and Their Association with Success Rate
The following test results need to be interpreted comprehensively. A single abnormal value does not mean IVF cannot be performed, but targeted management is needed. Before IVF in Thailand, it is recommended to complete a full fertility assessment. Some test results have limited validity (e.g., AMH and semen analysis are recommended within 3 months).
| Examination Indicator | Reference Range (Typical) | Relationship with Success Rate |
|---|---|---|
| AMH | >1.5 ng/mL | Above 1.5 indicates good ovarian reserve and ensures oocyte yield; below 0.5 usually yields ≤3 oocytes, requiring adjusted expectations |
| FSH (Day 2–4 of cycle) | <8 mIU/mL | Above 10 suggests diminished ovarian reserve; above 15 indicates poor response to stimulation |
| Antral Follicle Count (AFC) | >8 (both ovaries) | Total antral follicle count directly correlates with oocyte yield; below 5 indicates limited oocyte number |
| Sperm DNA Fragmentation Index (DFI) | <15% | Below 15% indicates better embryo quality; above 30% increases miscarriage risk |
| TSH | <2.5 mIU/mL | Above 2.5 is associated with increased miscarriage rate; adjustment to normal range before transfer is recommended |
| Vitamin D (25-OH) | >30 ng/mL | Supplementation recommended if below 20; deficiency reduces clinical pregnancy rate by approximately 30% |
| Endometrial Thickness (before transfer) | 7–14 mm | Too thin (<6 mm) or too thick (>16 mm) affects implantation rate; uterine cavity evaluation is needed |
It is important to note: AMH reflects the quantity of follicles, not their quality. Patients with low AMH can still have high-quality embryos, but they need a more appropriate stimulation protocol and adequate psychological preparation.
Special Situation: The Impact of PGT Screening on Success Rate
Thailand allows preimplantation genetic testing for aneuploidy (PGT-A), which is one of the main reasons some patients choose Thailand. The impact of PGT-A on success rate needs to be viewed objectively:
- Advantages: Selecting chromosomally normal embryos for transfer can reduce miscarriage rates and improve the live birth rate per single transfer. For patients over 38, with recurrent miscarriage, or repeated implantation failure, the benefits of PGT-A are more significant.
- Limitations: Approximately 30%–50% of blastocysts are identified as chromosomally abnormal during screening, reducing the number of transferable embryos. For young patients with a limited number of embryos (≤2), the risk of embryo loss due to screening needs to be weighed.
In clinical decision-making, the doctor will consider factors such as the patient's age, number of embryos, and previous pregnancy history to determine whether to recommend PGT-A. In some cases, PGT-SR (structural rearrangement screening) or PGT-M (monogenic disease screening) may also be considered for specific genetic issues.
Practitioner's Observation: Preparation Before IVF in Thailand
From ten years of observation in the assisted reproduction industry, the thoroughness of preparation directly affects the treatment experience and success rate before IVF in Thailand. The following matters are recommended to be completed in advance:
- Document preparation: Passports for both parties (valid for more than 6 months), notarized marriage certificate and translation. Some hospitals require double apostilled marriage certificates; it is recommended to confirm specific requirements 3 months in advance.
- Medical examinations: Complete fertility assessment reports (AMH, FSH, semen analysis, karyotype, infectious disease screening, etc.). Some test results are valid for 3–6 months; schedule rechecks according to your planned timeline.
- File establishment materials: Identification documents, marriage proof, medical examination reports, and genetic counseling records (if applicable). File establishment is usually done on day 2–4 of the menstrual cycle; advance booking is recommended.
- Time planning: From the first visit to completing embryo transfer, it usually takes 2–3 months (including ovarian stimulation, egg retrieval, embryo culture, PGT screening, and frozen embryo transfer). Older patients or those with diminished ovarian reserve should allow more time.
Thailand has a hot climate. After starting the cycle, it is advisable to reduce outdoor activities to avoid heatstroke and infection. Also, pay attention to food hygiene to avoid diarrhea affecting medication absorption.
⚠ Risk Reminder
Before IVF treatment in Thailand, it is recommended to complete a full fertility assessment, including chromosome testing for both partners, genetic counseling, and infectious disease screening. Do not make decisions based solely on age and hospital-promoted success rate data.
Success rate data are for reference only, not a guarantee. Each patient's individual situation is different; it is recommended to develop a personalized treatment plan under the guidance of a reproductive specialist. For patients of advanced age, with severely diminished ovarian reserve, or with specific genetic issues, be prepared mentally and financially for multiple treatment cycles.
When choosing a reproductive center in Thailand, it is advisable to verify the center's embryology lab qualifications, embryologist experience, and real data for your specific age group, rather than relying on fragmented online information. Be wary of any promise of a "guaranteed success."
—— The above content is based on consensus in the assisted reproduction industry and clinical practice, for medical reference.
